Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.
Abstract
UNLABELLED: Alaska Native people experience the highest rates of acute and chronic hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC) in the United States. We examined the effect of a universal newborn immunization with hepatitis B vaccine and mass population screening immunization program initiated in 1984 on rates of HBV and HCC in children 25 years later. During this time, the population of Alaska Native people grew from an estimated 75,000 to 130,000 persons. A surveillance system to detect acute HBV infection in Alaska Native facilities was established in 1981. Cases of HCC in children under 20 years of age were identified using a National Cancer Institute (NCI)-funded Cancer Registry established in 1969 coupled with an active surveillance program of screening persons with chronic HBV semiannually for alpha-fetoprotein since 1982. The incidence of acute symptomatic HBV infection in persons <20 years of age fell from cases 19/100,000 in 1981-1982 to 0/100,000 in 1993-1994. No cases of acute HBV have occurred in children since 1992. The incidence of HCC in persons <20 years decreased from 3/100,000 in 1984-1988 to zero in 1995-1999 and no cases have occurred since 1999. The number of identified hepatitis B surface antigen-positive children <20 years in the Alaska Native population declined from 657 in 1987 to two in 2008. CONCLUSION: Universal newborn vaccination coupled with mass screening and immunization of susceptible Alaska Natives has eliminated HCC and acute symptomatic HBV infection among Alaska Native children and this approach is the best way to prevent HBV-related disease in children.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Vaccine-induced immune memory has been demonstrated to persist for >30 years.
“Vaccine-induced immune memory has been demonstrated to persist for >30 years (1325–1327).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1326]
Cites
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883 · see citing works
The natural history of chronic hepatitis B virus infection #
McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.22898 · Cited by 879 · see citing works
McMahon, B. J., Alward, W. L. M., Hall, D. B., Heyward, W. L., Bender, T. R., Francis, D. P., & Maynard, J. E. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/151.4.599 · Cited by 832 · see citing works
Beasley, R. P., LEE, G. C.-Y., Roan, C., Hwang, L., Lan, C., Huang, F.-Y., & Chen, C.-L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90624-4 · Cited by 815 · see citing works
Mast, E. E., Margolis, H. S., Fiore, A. E., Brink, E. W., Goldstein, S. T., Wang, S. A., Moyer, L. A., Bell, B. P., & Alter, M. J. (2005) · PsycEXTRA Dataset · doi:10.1037/e548682006-001 · Cited by 751 · see citing works
A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein, S. T., Zhou, F., Hadler, S. C., Bell, B. P., Mast, E. E., & Margolis, H. S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi206 · Cited by 743 · see citing works
Newcombe, R. G. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90482-1 · Cited by 546 · see citing works
Epidemiology and Natural History of Hepatitis B
McMahon, B. J. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-915644 · Cited by 455 · see citing works
Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan
Chen, D. (1996) · JAMA · doi:10.1001/jama.276.11.906 · Cited by 341 · see citing works
McMahon, B. J., BULKOW, L. R., Harpster, A., Snowball, M. M., Lanier, A. P., Sacco, F. D., Dunaway, E., & Williams, J. (2000) · Hepatology · doi:10.1053/jhep.2000.17914 · Cited by 327 · see citing works
Liu, J., Yang, H., Lee, M., Lu, S., Jen, C., Wang, L., You, S., Iloeje, U. H., & Chen, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.048 · Cited by 265 · see citing works
Livingston, S., Simonetti, J., BULKOW, L. R., Homan, C., Snowball, M. M., Cagle, H. H., Negus, S. E., & McMahon, B. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.010 · Cited by 256 · see citing works
Seroepidemiology of Hepatitis B Virus Infection in Children
Chen, H. (1996) · JAMA · doi:10.1001/jama.1996.03540110060032 · Cited by 242 · see citing works
Chien, Y.-C. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj010 · Cited by 207 · see citing works
Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization Program
Harpaz, R., McMahon, B. J., Margolis, H. S., Shapiro, C. N., Havron, D., Carpenter, G., BULKOW, L. R., & Wainwright, R. B. (2000) · The Journal of Infectious Diseases · doi:10.1086/315259 · Cited by 156 · see citing works
Petersen, N. J., Barrett, D. H., Bond, W. W., Berquist, K. R., Favero, M. S., Bender, T. R., & Maynard, J. E. (1976) · Applied and Environmental Microbiology · doi:10.1128/aem.32.4.572-574.1976 · Cited by 116 · see citing works
GAVI, the first steps: lessons for the Global Fund
Brugha, R., Starling, M., & Walt, G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07607-9 · Cited by 107 · see citing works
Stroffolini, T., Mele, A., Tosti, M. E., Gallo, G., Balocchini, E., Ragni, P., Santonastasi, F., Marzolini, A., Ciccozzi, M., & Moiraghi, A. R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80132-4 · Cited by 106 · see citing works
McMahon, B. J., Heyward, W., Ritter, D., Wainwright, R. B., Rhoades, E., Tower, E., Lanier, A. P., & Helminiak, C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91557-1 · Cited by 103 · see citing works
Vaccination against hepatitis B: the Chinese experience.
Zhou, Y., Wu, C., & Zhuang, H. (2009) · PubMed · Cited by 98 · see citing works
Mele, A., Tosti, M. E., Mariano, A., Pizzuti, R., Ferro, A. M., Borrini, B. M., Zotti, C. M., Lopalco, P. L., Curtale, F., Balocchini, E., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/528687 · Cited by 80 · see citing works
PREVALENCE OF HEPATITIS B IN SELECTED ALASKAN ESKIMO VILLAGES
Schreeder, M. T., Bender, T. R., McMahon, B. J., MOSER, M. R., Murphy, B. L., Sheller, M. J., Heyward, W. L., Hall, D. B., & Maynard, J. E. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113659 · Cited by 70 · see citing works
Seroprevalence of Hepatitis B Viral Markers in 52,000 Alaska Natives
McMohon, B. J., Schoenberg, S., BULKOW, L. R., Wainwright, R. B., Fitzgerald, M. A., Parkinson, A. J., Coker, E., & Ritter, D. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116888 · Cited by 66 · see citing works
Wichajarn, K., Kosalaraksa, P., & Wiangnon, S. (2009) · PubMed · Cited by 66 · see citing works
Effect of a Hepatitis B Vaccination Program on the Prevalence of Hepatitis B Virus Infection
Mahoney, F. J., Woodruff, B. A., Erben, J. J., Coleman, P. J., Reid, E. C., Schatz, G. C., & Kane, M. A. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.1.203 · Cited by 57 · see citing works
Implementation of Newborn Hepatitis B Vaccination—Worldwide, 2006
(2009) · JAMA · doi:10.1001/jama.301.1.29 · Cited by 43 · see citing works
Primary hepatocellular carcinoma in alaskan natives, 1969–1979
Heyward, W. L., Lanier, A. P., Bender, T. R., Hardison, H. H., Dohan, P. H., McMahon, B. J., & Francis, D. P. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910280109 · Cited by 38 · see citing works
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 2,759 · see citing works
Global burden of primary liver cancer in 2020 and predictions to 2040
Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., Laversanne, M., McGlynn, K. A., & Soerjomataram, I. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.021 · Cited by 2,197 · see citing works
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652 · see citing works
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Cooke, G., Andrieux‐Meyer, I., Applegate, T. L., Atun, R. A., Burry, J., Cheinquer, H., Dusheiko, G. M., Feld, J. J., Gore, C., Griswold, M., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30270-x · Cited by 541 · see citing works
Paediatric cancer in low-income and middle-income countries
Magrath, I., Steliarova-Foucher, E., Epelman, S., Ribeiro, R. C., Harif, M., Li, C.-K., Kebudi, R., Macfarlane, S. D., & Howard, S. C. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70008-1 · Cited by 422 · see citing works
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 440 · see citing works
Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease
Nelson, N. P., Easterbrook, P., & McMahon, B. J. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.06.006 · Cited by 365 · see citing works
Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets
Spearman, C. W., Afihene, M., Ally, R., Apica, B. S., Awuku, Y. A., Cunha, L., Dusheiko, G. M., Gogela, N. A., Kassianides, C., Kew, M. C., et al. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(17)30295-9 · Cited by 362 · see citing works
Global Elimination of Chronic Hepatitis
Thomas, D. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1810477 · Cited by 330 · see citing works
The initiation and prevention of multiple sclerosis
Ascherio, A., Munger, K. L., & Lünemann, J. D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.198 · Cited by 288 · see citing works
Wen, W., Chang, M., Zhao, L., Ni, Y., Hsu, H., Wu, J., Chen, P., Chen, D., & Chen, H. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.015 · Cited by 268 · see citing works
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs
LOCARNINI, S. A., Hatzakis, A. E., Chen, D., & Lok, A. S.-F. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.018 · Cited by 262 · see citing works
Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
Chang, M., You, S., Chen, C., Liu, C., Lai, M., Wu, T., Wu, S., Lee, C., Yang, S., Chu, H.-C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.048 · Cited by 258 · see citing works
Chen, H., Lin, L., Hu, F., Lee, J., Lin, W., Yang, Y., Huang, F., Wu, S., Chen, S. C., Wen, W., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.12.035 · Cited by 257 · see citing works
White, M. C., Espey, D. K., Swan, J., Wiggins, C. L., Eheman, C. R., & Kaur, J. S. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301673 · Cited by 224 · see citing works
Disparities in liver cancer occurrence in the United States by race/ethnicity and state
Islami, F., Miller, K. D., Siegel, R. L., Fedewa, S. A., Ward, E., & Jemal, A. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21402 · Cited by 208 · see citing works
The Changing Epidemiology of Primary Liver Cancer
Petrick, J. L., & McGlynn, K. A. (2019) · Current Epidemiology Reports · doi:10.1007/s40471-019-00188-3 · Cited by 173 · see citing works
The evolution and clinical impact of hepatitis B virus genome diversity
Revill, P. A., Tu, T., Netter, H. J., Yuen, L. K. W., LOCARNINI, S. A., & Littlejohn, M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0296-6 · Cited by 169 · see citing works
Qu, C., Chen, T., Fan, C., Zhan, Q., Wang, Y., Lu, J., Lu, L., Ni, Z., Huang, F., Yao, H., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001774 · Cited by 151 · see citing works
Abara, W. E., Qaseem, A., Schillie, S. F., McMahon, B. J., & Harris, A. M. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1106 · Cited by 150 · see citing works
Mendy, M. E., Peterson, I., Hossin, S., Peto, T. J., Jobarteh, M. L., Jeng-Barry, A., Sidibeh, M., Jatta, A., Moore, S. E., Hall, A. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058029 · Cited by 143 · see citing works
Three decades of hepatitis B control with vaccination
Meireles, L. C. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i18.2127 · Cited by 134 · see citing works
Viral hepatitis: Past, present, and future
Odenwald, M. A., & Paul, S. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i14.1405 · Cited by 138 · see citing works
Hepatitis B vaccine development and implementation
Zhao, H. L., Zhou, X., & Zhou, Y. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1732166 · Cited by 126 · see citing works
What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats
Ward, J. W., & Hinman, A. R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.048 · Cited by 119 · see citing works
Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: A review
Sun, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14598 · Cited by 110 · see citing works
Current status and strategies for hepatitis B control in Korea
Cho, E. J., Kim, S. E., Suk, K. T., An, J., Jeong, S. W., Chung, W. J., & Kim, Y. J. (2017) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0104 · Cited by 106 · see citing works
Simons, B. C., Spradling, P. R., Bruden, D. J. T., Zanis, C., Case, S., Choromanski, T. L., Apodaca, M., Brogdon, H. D., Dwyer, G., Snowball, M., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw142 · Cited by 101 · see citing works
Hepatitis B vaccination and prevention of hepatocellular carcinoma
Kao, J. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.09.011 · Cited by 97 · see citing works
The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma
Flores, J. E., Thompson, A. J. V., Ryan, M. C., & Howell, J. A. (2022) · Vaccines · doi:10.3390/vaccines10050793 · Cited by 96 · see citing works
Chen, J., Jin, Z., Zhang, S., Zhang, X., Li, P., Yang, H., & Ma, Y. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00956-0 · Cited by 94 · see citing works
Ni, Y., Chang, M., Jan, C.-F. J., Hsu, H., Chen, H., Wu, J., & Chen, D. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.04.030 · Cited by 93 · see citing works
Lehtinen, M., Lagheden, C., Luostarinen, T., Eriksson, T., Apter, D. L., Harjula, K., Kuortti, M., Natunen, K., Palmroth, J., Petäjä, T., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-015867 · Cited by 90 · see citing works
Melkonian, S. C., Jim, M. A., Haverkamp, D. S., Wiggins, C. L., McCollum, J. T., White, M. C., Kaur, J. S., & Espey, D. K. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0288 · Cited by 90 · see citing works
Wen, W., Huang, C., Chie, W., Yeung, C., Zhao, L., Lin, W., Wu, J., Ni, Y., Hsu, H., Chang, M., et al. (2016) · Hepatology · doi:10.1002/hep.28589 · Cited by 87 · see citing works
Vaccines for immunoprevention of cancer
Enokida, T., Moreira, A., & Bhardwaj, N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146956 · Cited by 83 · see citing works
Long-term Protection After Hepatitis B Vaccine
Damme, P. V. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv750 · Cited by 81 · see citing works
Mysore, K. R., & Leung, D. H. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.06.002 · Cited by 78 · see citing works
Prevention of Hepatitis BPreprint
Chang, M., & Chen, D. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021493 · Cited by 73 · see citing works
Cancer vaccines: past, present and future; a review article
Grimmett, E., Al-Share, B. A., Alkassab, M. B., Zhou, R. W., Desai, A., Rahim, M. M. A., & Woldie, I. (2022) · Discover Oncology · doi:10.1007/s12672-022-00491-4 · Cited by 72 · see citing works
Gnyawali, B., Pusateri, A. J., Nickerson, A. M., Jalil, S., & Mumtaz, K. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i29.3793 · Cited by 72 · see citing works
Hepatitis B virus: where do we stand and what is the next step for eradication?
Komatsu, H. (2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8998 · Cited by 70 · see citing works
Persistence of long-term immunity to hepatitis B among adolescents immunized at birth
Chaves, S. S., Fischer, G. E., Groeger, J. L., Patel, P. R., Thompson, N. D., Teshale, E. H., Kuartei, S. J., Yano, V. M., Armstrong, G. L., Samandari, T., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.106 · Cited by 65 · see citing works
Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity
Cassidy, A., Mossman, S. P., Olivieri, A., Ridder, M. D., & Leroux-Roels, G. G. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.151 · Cited by 65 · see citing works
Ching, L. K., Gounder, P. P., BULKOW, L. R., Spradling, P. R., Bruce, M. G., Negus, S. E., Snowball, M. M., & McMahon, B. J. (2016) · Liver International · doi:10.1111/liv.13129 · Cited by 64 · see citing works
Cheung, K. W., Seto, M. T. Y., & Wong, S.-F. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.02.001 · Cited by 64 · see citing works
A blueprint for the primary prevention of cancer: Targeting established, modifiable risk factors
Gapstur, S. M., Drope, J. M., Jacobs, E. J., Teras, L. R., McCullough, M. L., Douglas, C. E., Patel, A. V., Wender, R. C., & Brawley, O. W. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21496 · Cited by 64 · see citing works
Chien, Y.-C., Jan, C.-F. J., Chiang, C., Kuo, H., You, S., & Chen, C. (2014) · Hepatology · doi:10.1002/hep.27048 · Cited by 59 · see citing works
Hepatocellular carcinoma in Australia's Northern Territory: high incidence and poor outcome
Parker, C., Tong, S. Y. C., Dempsey, K., Condon, J. R., Sharma, S. K., Chen, J. W. C., Sievert, W., & Davis, J. S. (2014) · The Medical Journal of Australia · doi:10.5694/mja13.11117 · Cited by 57 · see citing works
Hepatitis B – Vertical transmission and the prevention of mother-to-child transmission
Cheung, K. W., & Lao, T. T.-H. (2020) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.02.014 · Cited by 57 · see citing works
European Code against Cancer 4th Edition: Infections and Cancer
Villain, P., González, P., Almonte, M., Franceschi, S., Dillner, J., Anttila, A., Park, J. Y., Vuyst, H. D., & Herrero, R. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.10.006 · Cited by 54 · see citing works
Rosenberg, C. A., Bovin, N. V., Bram, L. V., Flyvbjerg, E., Erlandsen, M., Vorup‐Jensen, T., & Petersen, E. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24480 · Cited by 52 · see citing works
Stella, L., Santopaolo, F., Gasbarrini, A., Pompili, M., & Ponziani, F. R. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i21.2251 · Cited by 52 · see citing works
The impact of hepatitis B vaccine in China and in the China GAVI Project
Hadler, S. C., Fuqiang, C., Averhoff, F. M., Taylor, T. H., Wang, F., Li, L., Xiaofeng, L., & Weizhong, Y. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.043 · Cited by 51 · see citing works
Osiowy, C., Brenna, C., & Rempel, J. D. (2005) · Antiviral Therapy · doi:10.3851/imp2597 · Cited by 50 · see citing works
Hepatitis B Vaccination: A Historical Overview with a Focus on the Italian Achievements
Romanò, L., & Zanetti, A. R. (2022) · Viruses · doi:10.3390/v14071515 · Cited by 50 · see citing works
Prevention of Hepatitis B Virus Infection and Liver Cancer
Chang, M. (2013) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-38965-8_5 · Cited by 50 · see citing works
Spradling, P. R., BULKOW, L. R., Teshale, E. H., Negus, S. E., Homan, C., Simons, B. C., & McMahon, B. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.045 · Cited by 50 · see citing works
The importance of immunization in cancer prevention, treatment, and survivorship
Ward, E., Flowers, C. R., Gansler, T. S., Omer, S. B., & Bednarczyk, R. A. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21407 · Cited by 50 · see citing works
Unsolved problems and future perspectives of hepatitis B virus vaccination
Tajiri, K., & Shimizu, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i23.7074 · Cited by 50 · see citing works
Stroffolini, T., & Stroffolini, G. (2023) · Cancers · doi:10.3390/cancers15082388 · Cited by 49 · see citing works
Bosch, F. X., Tsu, V. D., Vorsters, A., Damme, P. V., & Kane, M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.090 · Cited by 49 · see citing works
Chronic hepatitis B in 2014: Great therapeutic progress, large diagnostic deficit
Niederau, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11595 · Cited by 48 · see citing works
Racial and Sex Disparities in Hepatocellular Carcinoma in the USA
Ajayi, F., Jan, J., Singal, A. G., & Rich, N. E. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00554-6 · Cited by 48 · see citing works
Lehtinen, M., Lagheden, C., Luostarinen, T., Eriksson, T., Apter, D. L., Bly, A., Gray, P. G., Harjula, K., Heikkilä, K., Hokkanen, M., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050669 · Cited by 48 · see citing works
Hu, Y., Zhang, S., Luo, C., Liu, Q., & Zhou, Y. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-221 · Cited by 47 · see citing works
Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review
Elbahrawy, A., Atalla, H., Alboraie, M. A. A., Alwassief, A., Madian, A., ElFayoumie, M., Tabll, A. A., & Aly, H. H. (2023) · Viruses · doi:10.3390/v15010214 · Cited by 41 · see citing works
Potentiating cancer vaccine efficacy in liver cancer
Tagliamonte, M., Petrizzo, A., Mauriello, A., Tornesello, M. L., Buonaguro, F. M., & Buonaguro, L. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1488564 · Cited by 36 · see citing works
Saffar, H., Saffar, M. J., Ajami, A., Khalilian, A., Shams-Esfandabad, K., & Mirabi, A. M. (2014) · Hepatitis Monthly · doi:10.5812/hepatmon.22223 · Cited by 35 · see citing works
Hepatitis B Vaccine: Four Decades on
Mironova, M., & Ghany, M. G. (2024) · Vaccines · doi:10.3390/vaccines12040439 · Cited by 34 · see citing works
Tosti, M. E., Alfonsi, V., Lacorte, E., Mele, A., Galli, C., Zanetti, A. R., & Romanò, L. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw162 · Cited by 33 · see citing works
Bouckaert, R., Simons, B. C., Krarup, H. B., Friesen, T. M., & Osiowy, C. (2017) · PeerJ · doi:10.7717/peerj.3757 · Cited by 30 · see citing works
International variations in childhood cancer in indigenous populations: a systematic review
Valery, P. C., Moore, S., Meiklejohn, J. A., & Bray, F. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70553-9 · Cited by 30 · see citing works
Miglietta, A., Quinten, C., Lopalco, P. L., & Duffell, E. F. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.6.17-00278 · Cited by 29 · see citing works
Incidence of primary liver cancer in American Indians and Alaska Natives, US, 1999–2009
Melkonian, S. C., Jim, M. A., Reilley, B. A., Erdrich, J., Berkowitz, Z., Wiggins, C. L., Haverkamp, D. S., & White, M. C. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1059-3 · Cited by 28 · see citing works
Moffat, J. M., Cheong, W.-S., Villadangos, J. A., Mintern, J. D., & Netter, H. J. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.02.042 · Cited by 28 · see citing works
Progress and Unfinished Business: Hepatitis B in the United States, 1980-2019
Bixler, D., Roberts, H., Panagiotakopoulos, L., Nelson, N. P., Spradling, P. R., & Teshale, E. H. (2023) · Public Health Reports · doi:10.1177/00333549231175548 · Cited by 27 · see citing works
Novel molecular targets in hepatocellular carcinoma
Chow, A. K.-M., Yau, S. W.-L., & Ng, L. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i8.589 · Cited by 27 · see citing works
Pol, S., & ANRS/AFEF study group (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16197 · Cited by 27 · see citing works
Lin, C., & Kao, J. (2020) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.01.010 · Cited by 27 · see citing works
Infantile Hepatitis B in Immunized Children: Risk for Fulminant Hepatitis and Long-Term Outcomes
Tseng, Y., Wu, J., Kong, M., Hu, F., Yang, Y.-J., Yeung, C., Huang, F., Huang, I., Ni, Y., Hsu, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111825 · Cited by 26 · see citing works
Sun, H., Cheng, C., Lee, N., Yang, C., Liang, S., Tsai, M., Ko, W., Liu, W., Wu, P.-Y., Wu, C.-H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090194 · Cited by 26 · see citing works
Michel, M., Bourgine, M., Fontaine, H., & Pol, S. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0381-y · Cited by 26 · see citing works
mTOR as a Potential Target for the Prevention and Treatment of Hepatocellular Carcinoma
Buitrago‐Molina, L. E., & Vogel, A. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912803988011 · Cited by 26 · see citing works
The Natural Course of Chronic Hepatitis B Virus Infection and Its Management
Hadziyannis, S. J., Vassilopoulos, D., & Hadziyannis, E. S. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-405880-4.00007-x · Cited by 24 · see citing works
Implementation of hepatitis B vaccine in high-risk young adults with waning immunity
Posuwan, N., Vorayingyong, A., Jaroonvanichkul, V., Wasitthankasem, R., Wanlapakorn, N., Vongpunsawad, S., & Poovorawan, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202637 · Cited by 24 · see citing works
The impact of hepatitis B vaccination in the United States, 1999–2018
He, W., Guo, G. N., & Li, C. (2021) · Hepatology · doi:10.1002/hep.32265 · Cited by 23 · see citing works
Zhao, H. L., & Zhou, Y. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1397243 · Cited by 23 · see citing works
Aypak, C., Yüce, A., Yıkılkan, H., & Görpelioğlu, S. (2012) · European Journal of Pediatrics · doi:10.1007/s00431-012-1815-4 · Cited by 22 · see citing works
Tajiri, H., Takano, T., Tanaka, H., Ushijima, K., Inui, A., Miyoshi, Y., Ozono, K., Abukawa, D., Endo, T., Brooks, S., et al. (2016) · Cancer Medicine · doi:10.1002/cam4.917 · Cited by 22 · see citing works
Cobertura de vacunación y proporción de esquema incompleto en niños menores de siete años en México
Díaz‐Ortega, J. L., Cruz‐Hervert, L. P., Ferreira-Guerrero, E., Ferreyra-Reyes, L. D., Delgado-Sánchez, G., & García‐García, L. (2018) · Salud Pública de México · doi:10.21149/8812 · Cited by 21 · see citing works
Strategies for Global Elimination of Chronic HBV Infection: 2019 Update
Nayagam, S., & Thursz, M. R. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00478-w · Cited by 21 · see citing works
Prevention of hepatitis B virus-related hepatocellular carcinoma
Lin, C., & Kao, J. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.125 · Cited by 21 · see citing works
A review of strategies to prevent mother-to-infant transmission of hepatitis B virus infection
Wen, W., Lai, M., & Chang, M. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1120667 · Cited by 21 · see citing works
Li, C., & He, W. (2021) · Liver International · doi:10.1111/liv.14821 · Cited by 21 · see citing works
Gómez-Quiroz, L. E., & Román, S. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100649 · Cited by 20 · see citing works
Stroffolini, T., Morisco, F., Ferrigno, L., Pontillo, G., Iantosca, G., Cossiga, V., Crateri, S., Tosti, M. E., & the SEIEVA Collaborating Group (2022) · Viruses · doi:10.3390/v14020245 · Cited by 19 · see citing works
Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care: Table 1.
McMahon, B. J., Block, J. M., Block, T. M., Cohen, C. A., Evans, A. A., Hosangadi, A., London, W. T., Sherman, M., & participants, O. B. O. T. 2. P. H. W. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv359 · Cited by 19 · see citing works
Damme, P. V., Ward, J. W., Shouval, D., & Zanetti, A. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00025-0 · Cited by 20 · see citing works
Vaccination contre le virus de l’hépatite B et prévention du cancer du foie
Lebossé, F., & Zoulim, F. (2020) · Bulletin du Cancer · doi:10.1016/j.bulcan.2020.10.014 · Cited by 18 · see citing works
- Authors
- McMahon, B. J., Bulkow, L. R., Singleton, R. J., Williams, J., Snowball, M., Homan, C., & Parkinson, A. J.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Alaska Native Tribal Health Consortium (US)
- Corresponding author
- McMahon, Brian J.
- Venue
- Hepatology
- Published
- 2011-09-02
- Volume
- 54
- Issue
- 3
- Pages
- 801-807
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1981017845
- Cited by
- 201
- References
- 28
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 8 · 2023: 14 · 2022: 12 · 2021: 15 · 2020: 17 · 2019: 8 · 2018: 14 · 2017: 16 · 2016: 15 · 2015: 15 · 2014: 18 · 2013: 20 · 2012: 8
- FWCI
- 12.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- hepatitis B virus, hepatocellular carcinoma, catch-up vaccination, Alaska Natives, hepatitis B surface antigen, alpha-fetoprotein screening, disease elimination
- MeSH terms
- Acute Disease, Adult, Child, Preschool, Hepatitis B, Carcinoma, Hepatocellular, Humans, Infant, Infant, Newborn, Liver Neoplasms, Time Factors, Hepatitis B Vaccines, Immunization Programs, Hepatitis B, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
